News

Article

Retinal imaging plays diagnostic role in COVID-19 cases

Author(s):

Investigators have found that optical coherence tomography findings could prove to be a diagnostic tool for COVID-19.

Retinal imaging should be an important part of the diagnostic process in potential cases of COVID-19 as optical coherence tomography (OCT) findings offer further hints of potential infection, according to a new study.

Results of the study were reported by first authors Jose M. Ortiz-Egea, MD, and Jorge Ruiz-Medrano, MD, from the Department of Ophthalmology at Castilla La Mancha University in Albacete, Spain, and Puerta de Hierro-Majadahonda University Hospital in Madrid, Spain, respectively, and José M. Ruiz-Moreno, MD, affiliated with both hospitals.

The following case report1 supports obtaining OCT images for patients with suspected COVID-19 infection.

A healthy 42-year-old caucasian male anesthetist reported acute development of a temporal relative scotoma in the left eye, the best-corrected visual acuity of which was 20/20.

Investigators noted that he had treated patients with COVID-19 over the prior 5 weeks. Most ocular findings were normal, with no discromatopsia or afferent pupillary defect.

Visual field testing showed no relevant findings associated with the focal loss of sensitivity, slit-lamp and fundus examinations appeared normal, and multimodal imaging showed or hypo- or hyper-autofluorescence in the area.

However, the investigators reported that a placoid, hyperreflective band at the level of the ganglion cell layer and the inner plexiform layer was seen in the swept-source OCT images. The outer retina was not affected at diagnosis and 1 month later.

The investigators noted that after the retinal examination, 7 days after symptom onset, the patient underwent an oropharyngeal swab test for SARS-CoV-2 RNA and an enzyme-linked immunosorbent assay (ELISA) to determine the immunoglobulin G and M levels.

A real-time reverse-transcriptase polymerase chain reaction was negative. ELISA testing and a third rapid antibody detection test performed 7 days after symptom onset were positive.

“The ocular signs and symptoms in COVID-19 cases are rarely reported, but may be underestimated, especially those that affect the retina and occur in asymptomatic or paucisymptomatic cases,” the authors concluded. “The current case of COVID-19 was diagnosed based on a retinal ophthalmic examination.”

See more COVID-19 coverage

---

Reference

1. Ortiz-Egea JM, Ruiz-Medrano J, Ruiz-Moreno JM. Retinal imaging study diagnoses in COVID-19: a case report. J Med Case Rep 2021;15(15) https://doi.org/10.1186/s13256-020-02620-5

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.